The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Cassava Sciences, Inc. (SAVA) is a stock that can certainly grab ...

A super easy and delicious bread can be made with just one ingredient: cassava flour! It's healthy and gluten-free. You ...

This is a curated list of the Bay Area’s most notable and permanent restaurant and bar closures, with new updates published ...

STAT+ subscribers can sign up here to get it delivered to their inbox. As we count down toward the December readout of ...

Cassava then released the altered data in a press release and investor deck, which led the SEC to allege that the company and ...

Cassava Sciences' stock is highly shorted, with potential reward tied to the upcoming Phase 3 trial results for simufilam.

Cassava, an award-winning French-California bistro in San Francisco’s North Beach neighborhood, is closing after 12 years in ...

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

Cassava Sciences, Inc. (SAVA) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Cassava Sciences' RETHINK-ALZ trial is nearing data release. See why SAVA stock could see volatility depending on trial ...

Top-line Data for RETHINK-ALZ 52-week Phase 3 trial Expected Before the End of 2024 $149.0 Million in Cash and Cash ...

Cassava Sciences ( (SAVA) ) has released its Q3 earnings. Here is a breakdown of the information Cassava Sciences presented to its investors.